Spencer Pharmaceutical Hires Regulatory Affairs Specialist

BOSTON, MA--(Marketwire - November 02, 2010) -

Dr. Lachance holds a Ph.D. in physiology and endocrinology from Laval University (Quebec, Canada) and a postdoctoral fellowship at a federal government research laboratory in Lennoxville (Canada). From 1992 to 1996, Dr. Lachance was a research associate at the University Hospital (CHUL) Research Center in Quebec City. He then joined the biopharmaceutical company Aeterna-Zentaris (formerly Aeterna Laboratories) where he held various positions with increasing responsibilities from Associate Director Process Development, to Associate Director Regulatory Affairs and Principal Director Quality Assurance. Since 2008, Dr. Lachance has been an independent consultant in Pharmaceutical development, Regulatory Affairs and Quality Assurance and he has been active as a member of the Canadian Association of Professional Regulatory Affairs (CAPRA), the US Drug Information Association (DIA) and the American Society for Quality (ASQ).

"We are pleased that Dr. Lachance has accepted our offer and will be an active and very valuable part of our team," said Dr. Arella, President of Spencer Pharmaceutical, Inc. "As a consultant to Spencer Pharmaceutical, Dr. Lachance will provide expertise in drug development, regulatory affairs, strategic planning and submissions. He will be an important asset in our goal of achieving high standards of quality in our product development," further added Dr. Arella.

About Spencer Pharmaceutical Inc.

Spencer Pharmaceutical Inc. is a US-based Pharmaceutical Research and Development Corporation, which is developing innovative drug release and absorption systems for the treatment of metabolic diseases such as diabetes and metabolic syndrome.

Important Information About Forward-Looking Statements in this press release may be "forward-looking statements" within the meaning of the Private Securities Litigation Reform Act of 1995. Words such as "anticipate," "believe," "estimate," "expect," "intend" and similar expressions, as they relate to the company or its management, identify forward-looking statements. These statements are based on current expectations, estimates and projections about the company's business based, in part, on assumptions made by management. These statements are not guarantees of future performance and involve risks, uncertainties and assumptions that are difficult to predict. Therefore, actual outcomes and results may, and probably will, differ materially from what is expressed or forecasted in such forward-looking statements due to numerous factors, including those described above. In addition, such statements could be affected by risks and uncertainties related to the exploration for and development of mineralized material, product demand, market and customer acceptance, competition, pricing and development difficulties, as well as general industry and market conditions and growth rates and general economic conditions. Any forward-looking statements speak only as of the date on which they are made, and the company does not undertake any obligation to update any forward-looking statement to reflect events or circumstances after the date of this release. Information on the Company's website does not constitute a part of this release.